Clinical trials for EEG

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to EEG. For all clinical trials, go to clinical trials search

This list shows clinical trials for EEG

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • EEG
Title Recruitment status Location
Simultaneous fMRI/EEG of the 4 mg nicotine lozenge in relief of cognitive impairment associated with nicotine withdrawal Not Recruiting United Kingdom
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder. A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months. Not Recruiting United Kingdom
Sleep electroencephalogram (EEG) recordings in interferon-alpha treated hepatitis C patients – Pilot Study Not recruiting United Kingdom
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder. A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months. Not Recruiting United Kingdom
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder. A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months. Not Recruiting United Kingdom
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder. A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months. Authorised United Kingdom
International Collaborative Study of a type of epilepsy called Infantile Spasms Authorised United Kingdom
International Collaborative Infantile Spasms Study (ICISS) - ICISS Authorised United Kingdom
Pulmonary surfactant (S) biology in ventilated children on a paediatric intensive care unit with acute (A) hypoxic respiratory (R) failure- a pilot (P) study (S): (SARPS) - SARPS Authorised United Kingdom
Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder. A 6-week randomised, double-blind parallel groups study versus comparator, followed by a double-blind optional treatment extension period up to 6 months. Efecto de agomelatina (25 a 50 mg/día) sobre los parámetros electroencefalográficos del sueño comparado con escitalopram en pacientes con Trastorno Depresivo Mayor.Estudio aleatorizado doble ciego, en grupos paralelos frente a comparador durante 6 semanas, seguido de un periodo de extensión opcional doble ciego hasta un total de 6 meses de duración. Authorised United Kingdom

Page last reviewed: 11/08/2015

Next review due: 01/08/2018